Medtronic is offering to exchange up to 225 million shares of MiniMed common stock it owns for Medtronic ordinary shares, aiming to complete its separation from MiniMed. Currently holding about 89.86% of MiniMed, Medtronic intends to exchange all its remaining shares without extending the offer period if oversubscribed. This move grants MiniMed full independence over its operations and capital decisions. The exchange offer is subject to SEC filings and investor decisions, marking a significant step in MiniMed's autonomy from Medtronic.
Medtronic has launched an exchange offer allowing its shareholders to swap their Medtronic shares for MiniMed Group shares at a 7% discount, expected to be tax-free for U.S. federal income tax purposes. MiniMed, formerly Medtronic's Diabetes business...
Medtronic and Abbott are both strong dividend-paying medical device companies, but Medtronic currently offers a higher dividend yield of 3.11% and stronger near-term growth prospects, including accelerating revenue and a planned diabetes business sep...
